Riskpilot← Back to searchSign inGet full accessAKAM Pharm i Mora AB
ABActiveOrg 5593452518Skålmyrsvägen 33 Apoteksgruppen MoraRetail sale of pharmaceutical products · NACE 4773Est. 20212 employees
Revenue 2024
SEK 12,5M
+28% vs 2023
EBITDA margin
7.7%
+7% vs 2023
Equity ratio
43.6%
Financial strength
Net profit 2024
SEK 531K
+39% vs 2023
| Revenue | SEK 12,5M | +28% |
| EBITDA | SEK 966K | +7% |
| Net profit | SEK 531K | +39% |
| Total assets | SEK 4M | +17% |
| Equity | SEK 1,8M | +13% |
| Employees | 2 | — |
Legal name
AKAM Pharm i Mora AB
Org number
5593452518
Legal form
Aktiebolag
NACE code
4773 · Retail sale of pharmaceutical products
Founded
9 november 2021
Share capital
SEK 100 000
Employees
2 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna suppleanten
Company purpose
Bolaget har till föremål för sin verksamhet att bedriva handel med receptbelagda apoteksvaror, receptfria apoteksvaror och handelsvaror som lämpar sig för försäljning och distribution till konsumenter genom apotek samt därmed förenlig verksamhet.
Address
Skålmyrsvägen 33 Apoteksgruppen Mora
Email
mora@apoteksgruppen.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2022 | 2023 | 2024 |
|---|---|---|---|
| Revenue | 2 753 | 9 771 | 12 492 |
| Staff expenses | −195 | −798 | −1 211 |
| EBITDA | 104 | 903 | 966 |
| Depreciation & amort. | −73 | −229 | −229 |
| EBIT | 31 | 675 | 737 |
| Net financials | −56 | −115 | −66 |
| Profit before tax | — | 478 | 671 |
| Tax | — | −95 | −140 |
| Net profit | −25 | 382 | 531 |
| Item | 2022 | 2023 | 2024 |
|---|---|---|---|
| Total assets | 3 444 | 3 435 | 4 031 |
| Equity | 1 175 | 1 557 | 1 759 |
| Long-term debt | 545 | 260 | 116 |
| Short-term debt | 1 724 | 1 618 | 2 156 |
| Total debt | 2 269 | 1 878 | 2 272 |
EBITDA margin
7.7%
This company
15.8%
Market median
-51% vs market
20222024
Equity ratio
43.6%
This company
38.2%
Market median
+14% vs market
20222024
Return on equity
30.2%
This company
18.4%
Market median
+64% vs market
20222024
Net profit margin
4.2%
This company
8.1%
Market median
-48% vs market
20222024
Asset turnover
3.10×
This company
1.12×
Market median
+177% vs market
20222024
Debt / equity
1.29×
This company
0.62×
Market median
-108% vs market
20222024
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
ME Chief Auditor | Chief Auditor | 2025 |
| Former (1) | ||
JL Chief Auditor | Chief Auditor | 2022 – 2025 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Deputy Board Member | 2024 | |
| Chairman | 2022 | |
| Board of Directors | 2022 | |
| Former (13) | ||
| Board of Directors | 2022 – 2024 | |
| Deputy Board Member | 2021 – 2022 | |
| Deputy Board Member | 2021 – 2022 | |
| Deputy Board Member | 2021 – 2022 | |
| Deputy Board Member | 2021 – 2022 | |
| Deputy Board Member | 2021 – 2022 | |
| Board of Directors | 2021 – 2022 | |
| Deputy Board Member | 2022 – 2024 | |
| Deputy Board Member | 2021 – 2022 | |
| Deputy Board Member | 2021 – 2022 | |
| Deputy Board Member | 2021 – 2022 | |
| Deputy Board Member | 2021 – 2022 | |
| Deputy Board Member | 2021 – 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 99% | 99% | 2023 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
AKAM AB
AKAM Pharm i Mora AB Board members of AKAM Pharm i Mora AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Malin Elisabeth Terneblad | Chief Auditor | 0 companies |
| Jonas Lars Lindgren | Chief Auditor | 0 companies |
| Karam Salah Polus Deesha | Board of Directors | 0 companies |
| Hans Jarl Rutger Arnhult | Deputy Board Member | 0 companies |
| Bo Daniel Falk | Deputy Board Member | 0 companies |
| Viktor Elias Bergman Gullmark | Deputy Board Member | 0 companies |
| Emma Maria Birgitta Wik | Deputy Board Member | 0 companies |
| Anna Matilda Sjödin | Deputy Board Member | 0 companies |
| Anders Nguyen | Deputy Board Member | 0 companies |
| Lars Anders Larsson | Board of Directors | 0 companies |
| Bashar Salah Polus Deesha | Deputy Board Member | 0 companies |
| Emelie Sofia Bergh | Deputy Board Member | 0 companies |
| Anna Carolina Maria Bjarnhagen | Deputy Board Member | 0 companies |
| Rolf Stefan Janse | Deputy Board Member | 0 companies |
| Alex Nordqvist | Chairman | 0 companies |
| Mari Sinikka Kovaniemi Feldt | Deputy Board Member | 0 companies |
| Olina Kristina Maria Wåhlstedt | Deputy Board Member | 0 companies |
| Mansoor Nasiri | Board of Directors | 0 companies |